VAERS reports by lot

Merck Pneumococcal lot T033369: VAERS reports

32 VAERS reports list lot T033369 as a Merck Pneumococcal vaccine, received between 2021-01-03 and 2022-08-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
3%
Marked serious
1
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2324%
Allergic / Anaphylactic1314%
General / Systemic (non-local)1314%
Dermatological (non-injection-site)1111%
Musculoskeletal1010%
Neurological99%
Cardiac / Cardiovascular99%
Respiratory44%
Gastrointestinal44%

Where reports came from

U.S. state of the reporter, where given (top 12).

Rhode Island3
Texas3
Oklahoma2
Wisconsin2
Indiana2
Missouri2
Oregon2
Alabama2
Tennessee2
Ohio2
Massachusetts1
North Dakota1

Reports by month received

2021-015
2021-022
2021-034
2021-042
2021-052
2021-062
2021-071
2021-081
2021-094
2021-101
2021-111
2021-121
2022-031
2022-073
2022-082

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.